Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 9, 2023
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, Aug 9th, 2023
Andrew Fein of HC Wainwright & Co., Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Aug 9th, 2023.
Andrew has made no other calls on ABOS in the last 4 months.
There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $14 on, Thursday, July 20th, 2023
- Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $13 on, Monday, July 17th, 2023
